Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
MXI1 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P50539 |
|---|---|
| Clone Names | 100525212 |
| Gene ID | 4601 |
|---|---|
| Other Names | Max-interacting protein 1, Max interactor 1, Class C basic helix-loop-helix protein 11, bHLHc11, MXI1, BHLHC11 |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | MXI1 |
|---|---|
| Synonyms | BHLHC11 |
| Function | Transcriptional repressor. MXI1 binds with MAX to form a sequence-specific DNA-binding protein complex which recognizes the core sequence 5'-CAC[GA]TG-3'. MXI1 thus antagonizes MYC transcriptional activity by competing for MAX. |
| Cellular Location | Nucleus. |
| Tissue Location | High levels found in the brain, heart and lung while lower levels are seen in the liver, kidney and skeletal muscle |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Expression of the c-myc gene, which produces an oncogenictranscription factor, is tightly regulated in normal cells but isfrequently deregulated in human cancers. The protein encoded bythis gene is a transcriptional repressor thought to negativelyregulate MYC function, and is therefore a potential tumorsuppressor. This protein inhibits the transcriptional activity ofMYC by competing for MAX, another basic helix-loop-helix proteinthat binds to MYC and is required for its function. Defects in thisgene are frequently found in patients with prostate tumors. Threealternatively spliced transcripts encoding different isoforms havebeen described. Additional alternatively spliced transcripts mayexist but the products of these transcripts have not been verifiedexperimentally.
References
Lofstedt, T., et al. Exp. Cell Res. 315(11):1924-1936(2009)Baranzini, S.E., et al. Hum. Mol. Genet. 18(4):767-778(2009)Tsao, C.C., et al. Cancer Biol. Ther. 7(10):1619-1627(2008)Suo, X.H., et al. Zhonghua Xue Ye Xue Za Zhi 28(11):745-749(2007)Dugast-Darzacq, C., et al. FEBS J. 274(17):4643-4653(2007)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
